Literature DB >> 14738870

Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway.

Guang Xu1, En Takashi, Mitsuhiro Kudo, Toshiyuki Ishiwata, Zenya Naito.   

Abstract

Although clinical diabetes mellitus is obviously a high risk factor for myocardial infarction, there is disagreement about the sensitivity of ischemic injury of an infarcted myocardium in experimental studies. The present study evaluated the influences of different durations of hyperglycemia on ischemic and reperfusion injuries of the myocardium, and focused on extracellular signal-regulated kinase 1/2 (ERK1/2), which plays an important role in the intracellular signaling pathway and is reported to be associated with myocardial protection against heart injury. Short- and long-term hyperglycemias were induced in rats by streptozotocin (STZ) injection and the rats were examined 4 (4WDM) and 20 weeks (20WDM) after the treatment. Ischemia and reperfusion were induced by occlusion and reperfusion (I/R) of the left coronary artery (LCA). I/R-induced infarct size was determined using triphenyltetrazolium chloride (TTC) staining. After 20 weeks of STZ treatment (20WDM+I/R), the infarct size in the rat heart increased by 65.2 +/- 4.3%, whereas after 4 weeks of STZ treatment (4WDM+I/R), the infarct size decreased compared with the time-matched I/R group (43.1 +/- 3.6% and 59.5 +/- 5.6%, respectively). The number of dead myocytes including necrotic and apoptotic cells was determined using horseradish peroxidase (HRP) and terminal deoxynucleotide nick-end labeling (TUNEL) methods. The number of dead myocytes decreased in the 4WDM+I/R group, while the number of dead myocytes increased markedly in the 20WDM+I/R group, compared with the time-matched I/R group. The increment of ERK1/2 phosphorylation in the 4WDM group and the slight enhancement of this phosphorylation by I/R treatment were observed by western blotting. However, in the 20WDM group, the level of ERK1/2 phosphorylation reduced by approximately 1/3 compared with the time-matched control group; moreover, I/R treatment did not enhance the phosphorylation level. This study demonstrated that short- and long-term hyperglycemias exert opposite influences on ischemic myocardial injury, and these contradictory influences may depend on an ERK1/2-mediated intracellular signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14738870     DOI: 10.1016/j.yexmp.2003.08.003

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  27 in total

1.  Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart.

Authors:  Ebru Gurel; Savas Ustunova; Aysegul Kapucu; Nadim Yilmazer; Otto Eerbeek; Rianne Nederlof; Markus W Hollmann; Cihan Demirci-Tansel; Coert J Zuurbier
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

Review 2.  Mitochondria as a target of cardioprotection in models of preconditioning.

Authors:  Magdaléna Jašová; Ivana Kancirová; Iveta Waczulíková; Miroslav Ferko
Journal:  J Bioenerg Biomembr       Date:  2017-07-20       Impact factor: 2.945

Review 3.  The biochemical alterations underlying post-burn hypermetabolism.

Authors:  Christopher Auger; Osai Samadi; Marc G Jeschke
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-20       Impact factor: 5.187

4.  Subcellular mechanisms of adaptation in the diabetic myocardium: Relevance to ischemic preconditioning in the nondiseased heart.

Authors:  T Ravingerová; A Adameová; J Matejíková; T Kelly; M Nemčeková; J Kucharská; O Pecháňová; A Lazou
Journal:  Exp Clin Cardiol       Date:  2010

5.  Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling.

Authors:  Guochuan Ma; Mohamed Al-Shabrawey; John A Johnson; Rahul Datar; Huda E Tawfik; Dehuang Guo; Ruth B Caldwell; R William Caldwell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-06       Impact factor: 3.000

Review 6.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

7.  Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system.

Authors:  Rakeshwar S Guleria; Rashmi Choudhary; Takemi Tanaka; Kenneth M Baker; Jing Pan
Journal:  J Cell Physiol       Date:  2011-05       Impact factor: 6.384

Review 8.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 9.  Impact of conditioning hyperglycemic on myocardial infarction rats: Cardiac cell survival factors.

Authors:  Christiane Malfitano; Alcione Lescano de Souza Junior; Maria Cláudia Irigoyen
Journal:  World J Cardiol       Date:  2014-06-26

10.  Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.

Authors:  Takayuki Miki; Tetsuji Miura; Hiroyuki Hotta; Masaya Tanno; Toshiyuki Yano; Takahiro Sato; Yoshiaki Terashima; Akifumi Takada; Satoko Ishikawa; Kazuaki Shimamoto
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.